Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/03/032083
CTRI/2021/03/032083
Not Yet Recruiting
Phase 2

A Clinical Study to Evaluate the Safety and Efficacy of Joshanda(Decoction) of Aftimoon(Cuscuta Reflexa Roxb) and Topical Application of Qust(Saussurea Lappa Clarke) with Honey in the Management of Kalaf(Melasma).

Central Council of Research in Unani Medicine New Delhi0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Council of Research in Unani Medicine New Delhi
Status
Not Yet Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council of Research in Unani Medicine New Delhi

Eligibility Criteria

Inclusion Criteria

  • •The following patients will be included:
  • •1\.Clinically diagnosed patients of Kalaf.
  • •2\.Irrespective of all genders.
  • •3\.patients between the age of 15 to 50 years.

Exclusion Criteria

  • •The following patients will be excluded:
  • •1\.Patients with history of Cardiovascular,Endocrine, Renal and Liver Diseases.
  • •2\.Skin sensitivity by history and clinical examination.
  • •3\.Pregnancy, Lactation and patients on oral contraceptives.
  • •4\.Patients on Anticoagulants.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential in male patients with anxiety.
CTRI/2023/07/055723Mprex Healthcare Pvt. Ltd.
Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential in female patients with anxiety.
CTRI/2023/08/056234Mprex Healthcare Pvt. Ltd.
Not Yet Recruiting
Phase 4
To evaluate the Safety and Efficacy of ACELABS Serum
CTRI/2024/02/063322Bright Diva Pte. Ltd.
Not Yet Recruiting
N/A
To study the effect of Panchakarma Essential in reducing symptoms with cardiopulmonarydisordersHealth Condition 1: I249- Acute ischemic heart disease, unspecified
CTRI/2023/11/060197Mprex Healthcare Pvt.Ltd. Wakad, pune
Completed
Phase 2
TO Find the Effect of LION�S MANE CAPSULE as Nutritional SupplementHealth Condition 1: E089- Diabetes mellitus due to underlying condition without complications
CTRI/2022/03/040725DXN Manufacturing India Pvt Ltd24